missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human AgRP C-Terminal Fragment Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Marque: R&D Systems™ 3726-AG-100
265.22 EUR valid until 2024-12-16
Use promo code "21630" to get your promotional price.
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
The Recombinant Human AgRP C-Terminal Fragment Protein is derived from E. coli. The Recombinant Human AgRP C-Terminal Fragment Protein has been validated for the following applications: Bioactivity.Spécification
| Lyophilized from a 0.2μm filtered solution in PBS. | |
| 5.6 kDa | |
| 100 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Recombinant |
| 181 | |
| AgRP/ART C-Terminal Fragment, aa 83-132 | |
| E. coli-derived human AgRP/ART protein Ser83-Thr132 | |
| Unconjugated | |
| 97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |